Received: 18 August 2020
Revised: 17 December 2020
Accepted: 27 January 2021
First Online: 24 March 2021
Ethics approval and consent to participate
: This study was approved by the medical ethical board of the Erasmus MC, reference number MEC-2018-1499. All included patients gave informed consent. This study was performed in accordance with the Declaration of Helsinki.
: All data supporting the findings of this study are available within the article and its information files and from the corresponding author upon reasonable request.
: R.H.J.M. reports research grants from Astellas, Bayer, Boehringer-Ingelheim, Cristal Therapeutics, Pfizer, Prostakan, Roche and Pamgene. Personal fees from Novartis and Servier; all outside the submitted work. R.W.F.v.L. reports research grants from Astellas, Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, Servier and Roche. Personal fees from Roche, Pfizer and Sanofi; all outside the submitted work. All other authors declare no potential competing interests.
: This study was funded by the Foundation Mitialto in the Netherlands. Foundation Mitialto had no role in any aspect of this study.